Knowledge Center

Poster / Oct 18, 2021

Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release

Authors:
  • Beatriz Noriega Fernandes
Source:
AAPS 2021

Track: Formulation and Delivery – Chemical
Monday, October 18, 2021 | 12:30 PM – 1:30 PM ET

Beatriz Noriega-Fernandes Inhalation and Advanced Drug Delivery R&D | ɫAV

Presenting Author:Beatriz Noriega-Fernandes-Scientist, Inhalation and Advanced Drug Delivery Group, R&D

Although drug delivery to the lung presents several advantages, its therapeutic efficiency is limited by a rapid clearance. Thus, this poster presentation will focus on the development of sustained release formulations suitable for lung delivery. The main goal will be to assess the impact of encapsulating a model drug (fluticasone propionate, FP) in 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) vesicles prior to spray-drying (SD) on the final product aerodynamic performance and dissolution.

Also in the Knowledge Center

Related Content

Membrane Technology

ɫAV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

ɫAV at a glance

Get to know more about our history

Page
Read more

Financial Stability

ɫAV is a well established and financially stable company

Page
Read more